Neuropilin-1 is upregulated in the adaptive response of prostate tumors to androgen-targeted therapies and is prognostic of metastatic progression and patient mortality

B. W.C. Tse, M. Volpert, E. Ratther, N. Stylianou, M. Nouri, K. McGowan, M. L. Lehman, S. J. McPherson, M. Roshan-Moniri, M. S. Butler, J. Caradec, C. Y. Gregory-Evans, J. McGovern, R. Das, M. Takhar, N. Erho, M. Alshalafa, E. Davicioni, E. M. Schaeffer, R. B. JenkinsA. E. Ross, R. J. Karnes, R. B. Den, L. Fazli, P. A. Gregory, M. E. Gleave, E. D. Williams, P. S. Rennie, R. Buttyan, J. H. Gunter, L. A. Selth, P. J. Russell, C. C. Nelson, B. G. Hollier*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

42 Scopus citations

Fingerprint

Dive into the research topics of 'Neuropilin-1 is upregulated in the adaptive response of prostate tumors to androgen-targeted therapies and is prognostic of metastatic progression and patient mortality'. Together they form a unique fingerprint.

Medicine & Life Sciences